Skip to main content
. 2021 Jul 20;2021(7):CD013196. doi: 10.1002/14651858.CD013196.pub2

NCT03558763 .

Study name Remote monitoring of patients with chronic obstructive pulmonary disease using a tablet system. A randomised cross‐over pilot study of feasibility evaluation and quality of life measurements
Methods Study design: unknown centres; open‐label blinding, cross‐over individual randomised controlled trial in Sweden
Duration: 56 weeks
Setting: unknown
Participants Population: 70 patients recruited from Sweden
Baseline characteristics: unknown
Inclusion criteria: diagnosis of COPD, GOLD grade D, FEV < 80% predicted, cognitive ability for study judged by investigator, living at home and able to manage daily living activities, gives informed consent and willing to participate, FEV₁/FVC (post bronchodilator) < 0.7
Exclusion criteria: COPD exacerbation during 1 month before study, severe disease other than COPD affecting HRQL as judged by investigator, long‐term stay away from home (> 2 weeks) w/o Internet connectivity
Interventions Measurements taken at baseline and at 26 weeks, 30 weeks, and 56 weeks
Treatment arms
  • Table system telemonitoring device with weekly video calls (first 4 weeks, then monthly thereafter)

  • Data obtained and uploaded twice weekly

Outcomes Primary outcomes: SF‐12
Secondary outcomes: cost‐utility evaluation
Starting date 06.07.2018
Contact information None listed
Notes Funding: Vastra Gotaland Region
Other identifier: NCT03558763